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Abstract (223 words) 
 
Fully consolidated fear memories can be maintained or inhibited by retrieval-dependent 
mechanisms depending on the degree of re-exposure to fear cues. Short exposures promote 
memory maintenance through reconsolidation and long exposures promote inhibition 
through extinction. Little is known about the neural mechanisms by which increasing cue 
exposure overrides reconsolidation and instead triggers extinction. Using auditory fear 
conditioning in male rats, we analysed the role of a molecular mechanism common to 
reconsolidation and extinction of fear, ERK1/2 activation within the basolateral amygdala 
(BLA), after intermediate CS exposure events. 
We show that an intermediate re-exposure (4 CS presentations) failed to activate ERK1/2 
in the BLA, suggesting the absence of reconsolidation or extinction mechanisms. 
Supporting this hypothesis, pharmacologically inhibiting the BLA ERK1/2-dependent 
signalling pathway in conjunction with 4 CS presentations had no effect on fear expression, 
and the NMDA receptor partial agonist D-cycloserine, which enhanced extinction and 
ERK1/2 activation in partial extinction protocols (7 CSs), had no behavioural or molecular 
effect when given in association with 4 CS presentations. 
These molecular and behavioural data reveal a novel retrieval-dependent memory phase 
occurring along the transition between conditioned fear maintenance and inhibition. CS-
dependent molecular events in the BLA may arrest reconsolidation intracellular signalling 
mechanism in an extinction-independent manner. These findings are critical for 
understanding the molecular underpinnings of fear memory persistence after retrieval both 
in health and disease. 
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Significance statement (120 words) 
 
Consolidated fear memories can be altered by retrieval-dependent mechanisms. Whereas a 
brief conditioned stimulus (CS) exposure promotes fear memory maintenance through 
reconsolidation, a prolonged exposure engages extinction and fear inhibition. The nature 
of this transition and whether an intermediate degree of CS exposure engages 
reconsolidation or extinction is unknown. We show that an intermediate cue exposure 
session (4 CSs) produces the arrest of ERK1/2 activation in the basolateral amygdala, a 
common mechanism for reconsolidation and extinction. Amnestic or hypermnestic 
treatments given in association with 4 CSs had no behavioural or molecular effects, 
respectively. This evidence reveals a novel retrieval-dependent memory phase. 
Intermediate degrees of CS exposure fail to trigger reconsolidation or extinction, leaving 
the original memory in an insensitive state.  
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Introduction  
Persistent maladaptive associative memories are an essential aspect of chronic, recurrent 
anxiety disorders, including specific phobias and post-traumatic stress disorder (Parsons 
and Ressler, 2013). In human and non-human animals, retrieval of an associative memory 
by means of exposure to the fear conditioned stimulus (CS) can trigger either the 
maintenance or inhibition of stored memories, depending on the number or extent of cue 
presentations. A brief CS presentation, in the presence of a mismatch between what is 
expected and what actually occurs, leads to memory reconsolidation and the maintenance 
of the conditioned response (Pedreira et al., 2004; Kindt et al., 2009). By contrast, a large 
number of CS presentations at re-exposure triggers extinction and inhibition of the 
conditioned response (Pavlov and Anrep, 1927; Bouton, 2004; Hermans et al., 2006). 
Intriguingly, although reconsolidation and extinction have opposite behavioural effects, 
both can be triggered by a similar event; a CS reminder without the US. Under extreme 
reminder conditions (brief or prolonged) memory trace dominance is evident since either 
reconsolidation or extinction is exclusively engaged (Eisenberg et al., 2003; Pedreira and 
Maldonado, 2003). Whether an intermediate degree of CS exposure triggers 
reconsolidation and/or extinction in a co-existent or mutually exclusive manner is unclear.  
Understanding how fear memory reconsolidation and extinction relate to each other 
when retrieval is triggered by intermediate amounts of CS exposure is essential fully to 
understand the alternative effects of retrieval on memory persistence. Moreover, since CS 
exposure is an essential aspect of existing treatments for anxiety disorders (Vervliet et al., 
2013), with growing interest in using pharmacological agents to potentiate their 
effectiveness (de Kleine et al., 2013), defining the boundary conditions - the characteristics 
of the transition from reconsolidation to extinction and the underlying molecular 
mechanisms - is essential for developing more effective therapies. 
Even though reconsolidation and extinction of cued fear memory are dependent 
upon distinct networks within the brain, the basolateral amygdala (BLA) is a locus for both 
processes (Nader et al., 2000; Maren, 2015), and within the BLA these memory processes 
rely on both exclusive and common neural mechanisms. Thus, reconsolidation specifically 
requires synthesis of the immediate early gene Zif268 (Lee et al., 2005), while extinction 
specifically requires the synthesis of the protein phosphatase calcineurin (Merlo et al., 
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2014). However, both processes rely on the antecedent activation of NMDA-type 
glutamate receptors (NMDAR) (Lee and Kim, 1998; Milton et al., 2013) and the 
extracellular signal-regulated kinase1/2 (ERK1/2) signalling pathway (Duvarci et al., 
2005; Herry et al., 2006). Thus, while reconsolidation and extinction are initiated by similar 
extra- and intra-cellular events, the transcriptional and translational events underlying each 
memory process are unique (Mamiya et al., 2009; Merlo et al., 2014).  
Because BLA ERK1/2 is activated by both fear memory reconsolidation and 
extinction, measuring CS exposure-dependent BLA pERK1/2 levels provides an ideal 
molecular marker to distinguish between the mutually exclusive or gradual coexistence 
hypotheses of these opposing processes (Perez-Cuesta and Maldonado, 2009). Thus, if the 
transition is gradual, with both memory processes being partially engaged, pERK1/2 
should be increased by an intermediate number of CS presentations. By contrast, a failure 
to affect BLA pERK1/2 levels by intermediate retrieval conditions would support a 
mutually exclusive three-phase transition. Therefore, in the present experiments we 
measured BLA pERK1/2 levels and the behavioural effect of ERK1/2 signalling cascade 
inhibition when fear memory was retrieved by presenting an intermediate number of CSs. 
We hypothesised that in rats with a fully consolidated auditory fear memory an 
intermediate number of CSs would fail to activate ERK1/2 in the BLA, supporting the 
three-phase transition hypothesis. 
We demonstrate here that 4 CS presentations had no effect on BLA pERK1/2 levels 
and left the fear memory insensitive to ERK1/2 blockade in the BLA. We thereby reveal a 
mutually exclusive relationship between reconsolidation and extinction and show that the 
transition between them as a result of increasing CS exposure is explained by a three-phase 
model.  
 
 
Materials and Methods 
Animals. Two hundred and fifty adult male Lister-Hooded rats weighing 250-300 g 
(Charles River, RGD_2312466) were used. All animals were kept under a 12 h light/dark 
cycle (lights off at 0700) and provided with food and water ad libitum except for during 
behavioural procedures. All animal procedures were conducted in accordance with the EU 
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legislation on the protection of animals used for scientific purposes (Directive 2010/63/EU) 
and the research was regulated under the Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review by the University of Cambridge 
Animal Welfare and Ethical Review Body (AWERB).  
Surgeries. Rats were anaesthetized with ketamine hydrochloride (100 mg/kg; Ketaset, Fort 
Dodge Animal Health) and xylazine (9 mg/kg; Rompun, Bayer), and implanted with 22-
gauge stainless steel bilateral indwelling guide cannulae (Plastics One) aimed at the BLA. 
The coordinates were 2.6 mm posterior to bregma, 4.5 mm lateral to the mid line and 3.6 
mm ventral to dura mater. Stainless-steel obturators were inserted to maintain patency 
during recovery and in between infusions.  
Intracranial microinfusions. Infusions were carried out as before (Merlo et al., 2014), with 
injectors extending 4mm beyond the guide cannulae. Prior to behavioural testing, animals 
were habituated to the infusion procedure by the administration of 0.1 µl of sterile saline 
solution per side (0.25 µl/min). U0126 (Sigma-Aldrich) was dissolved in 5% DMSO, 6% 
Tween 80, in 100 mM sterile phosphate-buffered saline (PBS, pH 7.2) to a final 
concentration of 2 µg/µl. 0.5 µl of U0126 or vehicle (5% DMSO, 6% Tween 80 in 100 
mM sterile PBS) solution per side (0.25 µl/min) were infused 30 min before re-exposure 
session. 
Behavioural procedures. Animals were initially individually habituated to the conditioning 
box (Paul Fray Ltd, UK) for 2 hours. On the training day, rats were placed in the box and 
after 25 minutes received an auditory conditioned stimulus (CS) presentation (60s clicker, 
10Hz, 80 dB) that was coterminous with the presentation of a scrambled footshock (US, 
0.5 mA, 0.5 sec) delivered through the grid floor. The training session consisted of two 
CS-US presentations with an inter-trial interval (ITI) of 5 minutes. Twenty four hours later 
the rats were returned to the box and presented with 1, 4, 7, or 10 CS presentations, ITI = 
1 min. Twenty-four hours later animals were again returned to the conditioning box and 
presented with one CS.  
Drug injection. The NMDAR partial agonist D-Cycloserine (DCS, Sigma-Aldrich) or the 
non-competitive receptor antagonist MK-801 were dissolved in sterile saline for 
intraperitoneal injection (1 ml/kg). The doses of 15 mg/kg (DCS) or 0.1 mg/kg (MK-801) 
were selected on the basis of their mnemonic effects on prior experiments on the 
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reconsolidation and extinction of fear memory (Merlo et al., 2014). Drug or saline solution 
injections were given 30 minutes before CS presentation sessions. 
Protein extraction and western blotting. Rats were sacrificed by carbon dioxide inhalation 
followed by neck dislocation. The brains were rapidly removed and snap frozen on dry ice 
prior to storage at -80°C. Cytosolic protein preparation, quantification and separation were 
performed as described before (Merlo et al., 2014). Blots were probed with: mouse anti-
ERK1/2 (#610124, BD Biosciences, AB_397530, 1:5000), rabbit anti-phospho-p44/42 
MAPK (ERK1/2) (Thr 202/ Tyr 204) (D13.14.4E) (Cell Signaling Tech, AB_10694057, 
1:500), mouse anti-β-actin [AC-15] (AbCam, AB_2223210, 1:50000), goat anti-rabbit-
HRP (Sigma, 1:10000) and rabbit anti-mouse-HRP (Sigma, 1:25000) diluted in Tris-
buffered saline solution containing 0.1% of Tween-20. A chemiluminescent signal was 
induced using an enhanced chemiluminescent reagent (Amersham) and images were 
captured using a cooled CCD camera (ChemiDoc-It, UVP). Signal analysis and 
quantification was performed using ImageJ software (v1.47a, NIH, SCR_003070). Each 
primary antibody working concentration was adjusted to deliver a linear relationship 
between the amounts of loaded protein in the blot versus signal intensity.  
Experimental design and statistical analysis. All training, CS presentation and test sessions 
were video recorded for offline behavioural analysis. The percentage of time freezing 
(absence of movement except for breathing) during the 1 minute prior to and during the 1-
minute CS was manually scored from the videos at 5 second intervals by an observer blind 
to the treatment. Statistical analyses of behavioural quantifications were performed using 
one-way, two-way or repeated measures ANOVAs, with Group as the between-subjects 
factor and CS-US or CS as the within-subjects factor. Tukey’s post hoc comparisons were 
used for further analysis. Any deviations from sphericity were corrected using the 
Greenhouse-Geisser correction if ε< 0.75, and the Huynh-Feldt correction if ε> 0.75 
(Cardinal and Aitken, 2006). For western blot data analysis, optical density (OD) values 
and the band areas were obtained for each microdissected basolateral amygdala cytosolic 
sample for both target protein (pERK1/2, ERK1/2) and the -actin loading control. Each 
pERK1/2 OD value was normalized to its corresponding ERK1/2 and -actin OD value. 
These normalised OD values for the experimental groups were normalised to the NR group 
mean OD value, and then averaged for each condition. To minimise variability across 
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membranes, each western blot membrane included at least three different samples of each 
experimental and control groups. Each western blot quantification was performed twice to 
ensure replicability. Molecular data were analysed using one-way ANOVA with Dunnett’s 
test for post hoc comparisons (Figure 1C). For western blot quantifications presented in 
Figure 4, OD values for SAL/Drug treated animals were normalised to the mean OD of 
their respective NR-SAL or NR-Drug group. These data were analysed using Student’s t-
test. In both cases Group was the between-subject factor. Tests were carried out using SPSS 
(IBM, SCR_002865) and JASP (University of Amsterdam, SCR_015823). 
 
Results 
Intermediate CS exposures fail to active BLA ERK1/2 
Rats were fear conditioned by two pairings of an auditory clicker (CS) and a footshock 
(US). Animals were divided according to the treatment received during re-exposure day 
into 5 experimental groups as follows: non-reactivated control group (NR), exposure to 1 
(1CS), 4 (4CS), 7 (7CS) or 10 (10CS) unreinforced 1-min long CS presentations (Figure 
1A). A mixed ANOVA indicated that all prospective groups showed similar acquisition of 
fear conditioning, with an effect of trial (CS-US1 vs. CS-US2, F (1, 60) = 468.3, p < 0.001, 
2 = 0.89) but no effect of group (F (4, 60) = 0.24, p = 0.91) or interaction (F (4, 60) = 0.10, p 
= 0.98) (Figure 1B). 
Twenty four hours later, animals were either re-exposed to the different numbers of CSs or 
remained in their home cages as controls (Figure 1B). Freezing to the first CS gives a 
measure of fear memory retention that can be assessed for all CS-exposed groups, to ensure 
that training was equivalent. All CS-exposed animals showed high levels of freezing to the 
first CS (preCS vs. CS1, F (1, 38) = 378.2, p < 0.001, 2 = 0.91) with no effect of group (F (3, 
38) = 0.52, p = 0.67) or any interaction (F (3, 60) = 0.72, p = 0.55), indicating similar levels 
of fear memory retention across groups. Repeated measures ANOVAs showed significant 
effects of trials on freezing level in 4CS (F (1.52, 13.71) = 20.18, p < 0.001, 2 = 0.69), 7CS (F 
(1.60, 11.23) = 5.31, p = 0.03, 2 = 0.43) and 10CS groups (F (2.71, 29.86) = 33.31, p < 0.001, 2 
= 0.75).  
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Twenty minutes after the presentation of the first CS, or immediately following removal 
from the home cage (NR group), animals were sacrificed and cytosolic protein extracts 
from the BLA prepared. A one-way ANOVA of BLA pERK1/2 levels quantified by 
western blots showed that the groups differed in their pERK1/2 level (F (4, 60) = 3.55, p = 
0.01, 2 = 0.19). Post hoc comparisons (Dunnett’s) showed that pERK1/2 was increased 
after 1 or 10 CS presentations (p = 0.01, p = 0.04, respectively) but remained at basal levels 
after 4 or 7 CSs (p = 0.62, p = 0.97, respectively, Figure 1C). 
We have previously shown that under these specific retrieval conditions, the presentation 
of one unreinforced CS leads to reconsolidation of the original memory, whereas 10 CS 
presentations leads to the formation of a new inhibitory extinction memory (Lee et al., 
2006; Merlo et al., 2014). Thus, these results confirmed the engagement within the BLA 
of the ERK1/2 signalling pathway under extreme reminder conditions, with both the 
reconsolidation- and extinction-inducing CS protocols resulting in kinase activation. By 
contrast, intermediate reminders of 4 or 7 CS presentations did not result in BLA ERK1/2 
activation. These observations support our main hypothesis indicating that a common 
synaptic plasticity mechanism engaged during either reconsolidation or extinction of fear 
memory is not recruited under these intermediate CS exposure conditions. 
 
ERK1/2 signalling cascade blockade during intermediate CS exposure has no effect 
on memory 
The lack of ERK1/2 activation after 4 or 7 CS presentations suggests that the CS exposure 
conditions leading to reconsolidation or extinction are separated by a degree of CS 
exposure during which no ERK-dependent synaptic plasticity mechanisms are engaged 
within the BLA. Alternatively, it is possible that during the transition period, both 
reconsolidation and extinction are taking place but in a gradual, or more subtle, way that is 
undetectable in BLA pERK1/2 levels. In order to distinguish between these two 
alternatives, we analysed the effect of specific inhibition of the ERK1/2 signalling pathway 
on fear memory after presentation of 4 or 7 CSs. In order to control for the amnestic effect 
of the pharmacological manipulation the experiment included groups of animals treated 
while undergoing either reconsolidation or extinction triggered by extreme CS exposure 
levels (1 or 10 CSs respectively). 
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Rats with bilateral cannulae targeting the BLA (Figure 2) were fear conditioned as before. 
Twenty four hours later animals received an intra BLA infusion of vehicle or the ERK1/2 
inhibitor U0126 30 minutes before the presentation of 1, 4, 7 or 10 CS. One day later fear 
memory was assessed by the presentation of one CS (Figure 3A). Intra-BLA infusion of 
U0126 had no acute behavioural effect during CS exposure sessions, with similar freezing 
levels across groups for the first CS (Group: F (3, 71) = 1.55, p = 0.21; Drug: F (1, 71) = 0.03, 
p = 0.87; Group x Drug: F (3, 71) = 0.35, p = 0.79), or along the session (4CS groups Drug: 
F (1, 19) = 0.21, p = 0.65, CS x Drug: F (3, 57) = 1.13, p = 0.35; 7CS groups Drug: F (1, 18) = 
0.46, p = 0.51, CS x Drug: F (3.28, 59.07) = 0.94, p = 0.43; 10CS Drug: F (1, 15) = 0.87, p = 0.37, 
CS x Drug: F (2.81, 42.19) = 1.18, p = 0.33; Figure 3B). At test, a two-way ANOVA revealed 
no overall effect of number of CS (F (3, 71) = 1.87, p = 0.14) or of ERK1/2 inhibition (F (1, 
71) = 0.03, p = 0.86), but a significant CS-Drug interaction, indicating differential effects of 
ERK1/2 inhibition with different levels of CS presentation (CS x Drug: F (3, 71) = 4.06, p = 
0.01, 2 = 0.15, Figure 3C). Simple main effects analysis showed an effect of drug for 1 
CS (F (1, 19) = 9.93, p = 0.005, 2 = 0.34) and 10 CS conditions (F (1, 17) = 5.10, p = 0.04, 2 
= 0.25), but not for 4CS (F (1, 19) = 0.004, p = 0.95) or 7CS groups (F (1, 18) = 0.32, p = 0.58). 
Given that some of our experimental conditions tested the null hypothesis (H0), i.e. the 
absence of U0126 effect (4 and 7 CSs), we also analysed these data using Bayesian 
statistics, a method not biased against H0 (Wagenmakers, 2007; Rouder et al., 2009). This 
revealed that the alternative hypothesis (H1) was 8.37 times more likely in animals 
receiving 1 CS and 2.04 times more likely in animals receiving 10 CSs (1CS data: BF01 = 
0.12; BF10 = 8.37. 10CS data: BF01 = 0.49; BF10 = 2.04). In contrast, in animals receiving 
4 CSs H0 was 2.55 times more likely whereas in animals receiving 7 CSs the null 
hypothesis was 2.25 times more likely (4CS data: BF01 = 2.55; BF10 = 0.39. 7 CS data: 
BF01 = 2.25; BF10 = 0.45). This analysis is consistent with the frequentist analysis presented 
above, further confirming the absence of an amnestic effect of U0126 when administered 
before 4 or 7 CS presentations.  
In addition to confirming previous observations on the requirement for BLA ERK1/2 in 
auditory fear memory reconsolidation and extinction (Duvarci et al., 2005; Herry et al., 
2006) in the 1CS and 10CS groups respectively, these data indicate that the same 
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intervention had no behavioural effect when animals are exposed to an intermediate 
number of CSs. 
The molecular and behavioural data presented so far indicate that both the 4 and 7 CS 
exposure conditions not only fail to trigger fear memory labilisation but also are 
insufficient to engage extinction. In order to further test the memory process dominance or 
absence in these two transitional stages we conducted the next series of experiments 
evaluating the effect of NMDAR activity modulation on the effective or ineffective 
activation of pERK1/2 in the BLA. 
 
BLA pERK1/2 enhancement by D-cycloserine (DCS) during intermediate CS 
presentations distinguishes between sensitive and insensitive transitional states 
The experiments presented here had two objectives: 1) to study the NMDAR activity 
dependence of BLA ERK1/2 activation during reconsolidation or extinction of fear 
memory, and 2) to evaluate the effect of NMDAR activity enhancement on the lack of BLA 
ERK1/2 activation seen after 4 or 7 CS presentations. Systemic NMDAR activity 
manipulations were carried out using the NMDA receptor antagonist MK-801 or partial 
agonist DCS. 
In order to test the requirement for NMDAR activity in reconsolidation- or extinction-
induced BLA ERK1/2 activation, rats were fear conditioned as before. Twenty four hours 
later animals were injected systemically with saline or MK-801 30 minutes before 1 or 10 
CS presentations. Twenty minutes after the first CS presentation, animals were sacrificed 
and their brains removed. Non-reactivated control groups (NR) received the same i.p. 
injections, but were returned to their home cages, and sacrificed 50 minutes later. In order 
to test for the effect of CS exposure on BLA pERK1/2 level depending on drug condition 
we performed unpaired t-tests on western blot data. This analysis shows that 1 CS 
presentation induced an increase in BLA pERK1/2 in the saline group (t(14) = 3.08; p = 
0.004) whereas there was no change in the presence of MK-801 (t(14) = 0.07; p = 0.47; 
Figure 4A). Similarly, there was a pERK1/2 increase in rats injected with saline and 
exposed to 10CS (t(14) = 2.83; p = 0.006) but not in rats treated with MK-801 (t(14) = 
1.04; p = 0.16; Figure 4B). These data are consistent with the disruption of reconsolidation 
or extinction by NMDAR blockade under extreme CS presentation conditions, and 
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demonstrate that NMDAR activation is required for the increase in pERK1/2 associated 
with both of these mnemonic processes. 
In parallel we analysed the effect of NMDAR activity enhancement on the BLA ERK1/2 
activation state after 4 or 7 CS presentations, hypothesising that if there is a mnemonic 
insensitive period engaged by these levels of CS presentation, then it should not be possible 
to modulate pERK1/2 level by enhancing NMDAR activity. Twenty four hours after fear 
conditioning, rats were injected with saline or DCS 30 minutes before 4 or 7 CS 
presentations. Twenty minutes after the first CS presentation, animals were sacrificed and 
their brains removed. Non-reactivated control groups were treated as before. Animals 
exposed to 4 CS presentations showed no change in BLA pERK1/2 levels in both the saline 
(t(8) = 1.09; p = 0.16) or DCS condition (t(8) = 0.78; p = 0.23; Figure 4C). By contrast, 
animals exposed to 7 CS presentations showed no difference in pERK1/2 levels when 
injected with saline (t(8) = 0.29; p = 0.39) but a significant increase in the activated kinase 
levels when injected with DCS (t(8) = 2.12; p = 0.03; Figure 4D).   
These results indicate that ERK1/2 activation by reconsolidation or extinction of fear 
memory is dependent on NMDAR activity. Also, they show that enhancement of NMDAR 
activity increased pERK1/2 levels only in the 7CS group, suggesting that the two 
transitional states induced by 4 or 7 CSs engage qualitatively different neural mechanisms. 
 
Discussion 
We have previously proposed that the transition from reconsolidation to extinction induced 
by increasing CS exposure conformed to a three-phase transition model that is 
characterised by an intermediate insensitive memory phase (Merlo et al., 2014). Since that 
hypothesis was based solely on behavioural observations following systemic 
pharmacological manipulations, it was possible that the lack of a memory modulation 
effect after 4 CSs was the result of simultaneous and opposing effects on both 
reconsolidation and extinction mechanisms that were partially engaged in the brain. In the 
present study we used a complementary molecular biological and behavioural approach 
along with more specific intra-BLA pharmacological manipulations to investigate the 
existence of this novel retrieval-dependent memory process triggered by intermediate 
degrees of cue exposure at memory retrieval. We show that activation of the BLA ERK1/2 
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signalling pathway, a well-established molecular marker for reconsolidation and extinction, 
reveals a mutually exclusive, three-phase transition between these memory processes when 
non-reinforced CS exposure is increased. Whereas extreme reminder conditions that 
trigger either fear memory reconsolidation or extinction (1 or 10 CS) resulted in an increase 
in BLA pERK1/2, intermediate reminders (4 or 7 CS) failed to alter BLA pERK1/2 levels. 
This transition mode was corroborated by pharmacological manipulation of ERK1/2 
signalling pathway or NMDA-type glutamate receptor activity. Thus, intra-BLA inhibition 
of the ERK1/2-dependent signalling cascade by U0126 disrupted both reconsolidation and 
extinction, but had no behavioural effect under intermediate CS exposure protocols. 
However, systemic DCS treatment revealed a distinction between 4 and 7 CS conditions, 
since it failed to affect BLA ERK1/2 activation at 4 CS, but increased it at 7 CS, when it is 
also able to enhance extinction (Merlo et al., 2014).  
It is well established that the ERK1/2 signalling pathway within the BLA is an 
essential mechanism underlying consolidation, reconsolidation and extinction of auditory 
fear memory (Schafe et al., 2000; Duvarci et al., 2005; Herry et al., 2006). In particular, it 
has been shown that intra-BLA administration of U0126 does not permanently damage the 
BLA, and has an amnestic effect only if the fully consolidated fear memory is retrieved 
(Duvarci et al., 2005). Here we show that during an intermediate reminder this amnestic 
manipulation is without effect even in presence of fear memory retrieval (Fig. 3). Although 
retrieval is a necessary condition for ERK1/2 blockade in the BLA to have an amnestic 
effect, it is not sufficient. U0126 can only exert its amnestic effect when infused into the 
BLA when either reconsolidation or extinction has been engaged.  
 The effect of 4 CS presentations on the fear response towards the CS at test is not 
significantly different to that of the 1 CS group, but is invariably at a lower level (1CS-
VEH vs. 4CS-VEH in Fig. 3C and (Merlo et al., 2014)). A similar extinction-independent 
decrease in a contextual fear response was observed at test after intermediate context 
exposure (Cassini et al., 2017).  It remains to be determined how 4 CSs affect the original 
fear memory. They may act to reduce the stored CS-US contingency information through 
a mechanism independent of extinction, affecting the original memory trace in the absence 
of reconsolidation. Such a mechanism could produce conditioned fear reduction without 
reinstatement, renewal or spontaneous recovery. Interestingly, 7 CS presentations did 
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produce a reduction of fear at test in comparison with the 1 CS group, suggestive of the 
early engagement of extinction mechanisms. Even though this is an indirect observation, it 
supports the qualitative difference between these two intermediate reminder conditions 
discussed above. 
As shown here, the molecular biological or behavioural analyses conducted 
separately do not fully reveal the complexity of memory mechanisms taking place during 
the transition from reconsolidation to extinction. This exemplifies the necessity of 
combining these approaches in order fully to understand these mechanisms. Failure to 
promote ERK1/2 activation in the BLA after an intermediate reminder does not provide a 
true biomarker of memory in limbo since this was also observed in both 4 and 7 CS 
conditions. The lack of a memory enhancing effect of BLA ERK1/2 positive modulation 
following DCS is therefore further evidence of the limbo state. These two sources of 
experimental evidence, while affirming the existence of the limbo state, cannot rule out the 
possibility of a third mnemonic process interposed between reconsolidation and extinction 
and this warrants further detailed experimental investigation. 
 
Reconsolidation and extinction: mutually exclusive vs coexistence hypotheses 
In an attempt to distinguish between these alternative hypotheses previous reports have 
investigated the pharmacological effects of amnestic treatments during intermediate CS 
exposure. In medaka fish, exposure to the amnestic agent 3-aminobenzoic acid ethyl ester 
(that can prevent both reconsolidation and extinction) during an intermediate CS exposure 
session had no behavioural effects (Eisenberg et al., 2003). In rats, systemic administration 
of an NMDAR agonist or antagonist had no effect when given in association with an 
intermediate fear or appetitive memory retrieval session (Flavell and Lee, 2013; Merlo et 
al., 2014). Finally, a period of insensitivity has been reported for a fear memory in humans 
after an intermediate exposure session and oral administration of the beta adrenoceptor 
antagonist, propranolol, which prevents reconsolidation after brief memory reactivation 
(Sevenster et al., 2014). Even though these are consistent observations from fish to humans, 
the lack of specificity of the pharmacological manipulations used in these studies makes it 
difficult to distinguish between the two alternative memory dominance hypotheses (Perez-
Cuesta and Maldonado, 2009). 
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Here we present molecular and behavioural evidence indicating that 
reconsolidation and extinction do not co-exist and that there is a limbo memory state when 
BLA ERK1/2 and fear expression are immune to amnestic and hypermnestic manipulations. 
The combination of precise parametric control of CS exposure levels with a well 
characterised amnestic treatment, the ERK1/2 inhibitor U0126 (which blocks both 
reconsolidation and extinction under extreme CS exposure conditions) allows us to reject 
the co-existence hypothesis and reveal the existence of an impervious, limbo memory state. 
 The parametric conditions that determine the engagement of alternative retrieval-
dependent memory processes also depend on memory acquisition conditions (i.e: US 
intensity, CS duration) or memory age. Stronger or older fear memories require an 
extended CS re-exposure event in order to engage memory reconsolidation when compared 
to a younger or weaker memory (Suzuki et al., 2004). Contextual fear memories trained 
with longer context exposure bouts before shock presentation showed a rightwards shift in 
the three-phase transition profile of reconsolidation, ‘limbo’ and extinction (Alfei et al., 
2015). Moreover, under the experimental conditions used here, it was the intermediate 
number of 4 CS presentations that failed to trigger reconsolidation or extinction. It is 
therefore possible that the degree of CS exposure necessary for ‘limbo’ engagement will 
be sensitive to conditions such as US intensity at training, CS frequency at re-exposure or 
total CS exposure time. 
 
  
Molecular markers of memory in limbo 
Activation of the ERK1/2 signalling pathway is a conserved mechanism underlying 
memory consolidation, reconsolidation and extinction in key brain areas and in a variety 
of memory paradigms (Cestari et al., 2014). Its ubiquitous function, combined with its 
activation time course, suggests ERK1/2 is an ideal candidate marker to study the transition 
from reconsolidation to extinction by increasing the number of non-reinforced CS 
presentations. Our experiments confirm the requirement for BLA ERK1/2 activation in 
both the reconsolidation and extinction of fear memory (Duvarci et al., 2005; Herry et al., 
2006) and also show for the first time that an intermediate number of CS presentations fails 
to activate the kinase, leaving it at the level seen in a trained, but not reminded, control 
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group. These data suggest that within a limited range, increasing CS exposure terminates 
the labilisation of the original CS-US memory, without necessarily engaging memory 
extinction. This intriguing finding has several theoretical implications for the neural 
mechanisms of memory persistence upon retrieval. 
In the procedure employed here, 4 CS presentations terminated the incipient 
memory labilisation and restabilisation mechanisms triggered by the first CS. We speculate 
that one or more CS-dependent molecular events may mediate this arrest of the earliest 
reconsolidation intracellular signalling mechanism in an extinction-independent manner. 
For example, a protein-protein interaction that reduces or buffers Ca2+ flow through the 
NMDAR could be activated by 4 CSs to act as an early molecular brake that disengages an 
ongoing synaptic plasticity mechanisms (Cho et al., 2001). Additionally, given that 
memory labilisation is required for reconsolidation and depends on degradation of pre-
existing post-synaptic proteins via activation of the ubiquitin proteasome system (Lee et 
al., 2008), labilisation arrest could require the activation of specific de-ubiquitinating 
enzymes (DUBs) within the BLA. The DUB ubiquitin carboxy-terminal hydrolase L1 is 
highly specific to neurons and suppresses TNF-α induced ERK1/2 activation in vitro 
(Ichikawa et al., 2010).  
Animals receiving 7 CS presentations also showed lack of BLA ERK1/2 activation, 
but were nevertheless molecularly and behaviourally sensitive to the effect of NMDAR 
agonism, since DCS potentiated the emerging dominant memory process of extinction. 
This important difference between two intermediate states highlights both the insensitivity 
of the intracellular signalling cascade after 4 CS presentations and also that extinction 
engagement is a gradual process developing after a sufficient number of CS presentations 
(between 4 and 7) and requiring the concerted action of kinases and phosphatases (de la 
Fuente et al., 2011; Merlo et al., 2014). Systemic DCS administration increased BLA 
calcineurin levels after 7 CS presentations, leading to extinction enhancement, but had no 
effect on the phosphatase levels after 4 CSs (Merlo et al., 2014). Even though 
reconsolidation termination and the gradual engagement of extinction are both CS 
repetition-dependent events, it remains to be determined whether the molecular changes 
such as ERK1/2 activation occur in the same or different neuronal subpopulations within 
the BLA. We speculate that the CS-dependent early inactivation of ERK1/2 takes place in 
17 
 
the fear neuronal ensemble, which stops responding to the CS as a consequence of 
extinction training. As more unreinforced CSs are presented, extinction neurons may then 
increase their firing rate in response to the extinguished CS through an ERK1/2-dependent 
mechanism (Herry et al., 2008). Defining the molecular mechanisms that act to arrest 
reconsolidation, manifesting as ERK1/2 insensitivity to CS exposure, will be an important 
next step in order to test putative interactions between these opposing memory maintenance 
and inhibition processes. 
 
Clinical implications of memory in limbo 
A widely used and effective treatment for anxiety disorders is exposure therapy. 
Manipulation of memory content during exposure sessions either by enhancing memory 
extinction or preventing memory reconsolidation is emerging as a promising development 
of such treatments (Bowers and Ressler, 2015). In this context, the use of DCS during 
exposure sessions has shown a positive (Guastella et al., 2008; Otto et al., 2010), negative 
(Smits et al., 2013) or no effect in patients with anxiety disorders (de Kleine et al., 2012). 
Furthermore, pharmacological treatment in association with traumatic memory 
reactivation involving CS exposure has also shown positive (Brunet et al., 2008; Kindt and 
van Emmerik, 2016) or no effect (Wood et al., 2015) in PTSD patients. We suggest that 
this pattern of results is consistent with the three component transition between 
reconsolidation and extinction reported here. Depending on the strength of the maladaptive 
aversive memory, CS exposure protocols will affect fear memory differently, but 
invariably the profile will follow the same transitions occurring during the CS exposure 
space. A pharmacological treatment such as DCS will enhance reconsolidation or 
extinction when using extreme CS exposure sessions, but will have no effect when CS 
exposure results in a memory in limbo. Conversely, if CBT is combined with an amnestic 
treatment in order to disrupt the traumatic memory, unintentional limbo engagement 
through an extended CS exposure session will leave the target memory in an insensitive 
state thereby preventing clinical improvement. The degree of CS exposure resulting in 
limbo could vary between individuals, perhaps due to differences in learning history, but 
knowing of the existence of a limbo state both helps to understand contradictory findings 
and also promote the development of new treatments to enhance exposure therapy. 
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Figure legends 
 
Figure 1. Intermediate cue exposure fails to activate BLA ERK1/2, a molecular marker of 
fear memory reconsolidation and extinction. (A) Experimental design. Rats were fear 
conditioned with two CS-US pairings. Twenty four hours after training, animals were 
divided into 5 groups as follows: non-reactivated control (NR), 1, 4, 7 and 10 CS 
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presentations (1CS, 4CS, 7CS or 10CS, respectively). Twenty minutes after the first CS 
presentation, or straight from the home cage, animals were sacrificed and BLA cytosolic 
protein extracts prepared. (B). Mean (± SEM) of % time freezing during cued fear 
conditioning and at different number of cue exposure sessions (NR n = 23, 1CS n = 12, 
4CS n = 10, 7CS n = 8, 10CS n = 12). (C) Representative western blot picture and analysis 
of pERK1/2 levels in the BLA for NR, 1CS, 4CS, 7CS and 10CS groups. Mean relative 
optical density as % of NR (± SEM) shows that pERK1/2 is increased after 1 or 10 CS 
presentations, but unchanged after 4 or 7CSs. TR: training session. *: p< 0.05. 
 
Figure 2. Injector tip placements within the basolateral amygdala for each experimental 
condition: 1CS, 4CS, 7CS and 10CS. Vehicle: open circles; U0126: closed circles. 
Modified from Paxinos & Watson (Paxinos and Watson, 1998). 
 
Figure 3. Intra-BLA administration of U0126, a specific inhibitor of ERK1/2 pathway, has 
no behavioural consequences during intermediate CS exposure. (A) Experimental design. 
Animals were trained with two CS-US pairings. Twenty four hours later they were injected 
with vehicle or U0126 (1 µg per side) and within each drug condition divided into four 
groups (1CS, 4CS, 7CS and 10CS) depending on the number of cue presentations. Twenty 
four hours later all the animals were tested for fear memory with the presentation of one 
CS (1CS VEH and 4CS U0126 n = 11; 10CS VEH n = 7; remaining groups n = 10 per 
group). (B and C) Mean % of time freezing (± SEM) at CS exposure sessions (B) or long-
term memory test (C) are shown. TS: test session. *: p<0.05; **: p<0.01. 
 
Figure 4. NMDAR-dependent BLA ERK1/2 activation distinguishes between sensitive 
and insensitive transitional states between fear memory reconsolidation and extinction. (A) 
Experimental design: Twenty four hours after training animals were i.p. injected with 
saline or MK-801 (0.1 mg/kg) and then exposed to 1 CS (1CS groups) or returned to the 
home cage (NR groups). Fifty minutes after the injection the animals were sacrificed and 
BLA cytosolic protein extracts prepared. Representative western blot pictures. Bar graph 
shows the mean BLA level of pERK1/2 (± SEM) as a % of NR group (n = 8 per group). 
Open bars: saline injection; striped bars: MK-801 injection. (B) Experimental design and 
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bar graph: same as for A, but after i.p. injection the animals were either returned to the 
home cage (NR groups) or exposed to 10 CS presentations (10CS groups) (n = 8 per group). 
(C) Experimental design: 24h after training animals were i.p. injected with saline or DCS 
(15 mg/Kg) and then exposed to 4 CS (4CS groups) or returned to the home cage (NR 
groups). Fifty minutes after the injection the animals were sacrificed and BLA cytosolic 
protein extracts prepared. Representative western blot pictures. Bar graph shows the mean 
BLA level of pERK1/2 (± SEM) as a % of NR group (n = 5 per group). Open bars: saline 
injection; striped bars: DCS injection. (D) Experimental design and bar graph: same as for 
C, but after i.p. injection the animals were either returned to the home cage (NR groups) or 
exposed to 7 CS presentations (7CS groups) (n = 5 per group). *: p < 0.05 vs. NR group 
receiving the same i.p. injection. 
 




